Background: HIV-uninfected individuals with pulmonary TB (PTB) commonly present with radiological features of upper lobe cavitatory disease. In contrast, individuals with HIV and PTB may present differently. This study compared radiological features of individuals with laboratory-confirmed PTB by HIV status from the largest study in South Africa.
Introduction
South Africa has one of the highest estimated TB rates in the world with approximately 461 000 new cases each year, with 73% of patients with TB also carrying HIV infection. 1 Diagnosis of pulmonary TB (PTB) is based on clinical history, Mycobacterium tuberculosis detection in sputum samples by culture, smear, nucleic acid amplification and/or chest radiograph (CXR). In HIVuninfected individuals, PTB typically presents on CXR as an upper lobe disease with cavitations, formed as a result of a cellmediated response involving a variety of host immune cells that eventually undergo caseous necrosis and fragmentation. 2 As a result of CD4 T-cell depletion, individuals with HIV may have a compromised response, a defect that most likely underpins the biological mechanism for why HIV-associated PTB may present differently on CXR. Consistent with this, several smaller studies report atypical radiological findings in individuals with HIV. [3] [4] [5] A substantial portion of individuals with HIV with sub-clinical disease may go undiagnosed, underscoring the importance of providing unequivocal evidence of differential CXR presentation in this vulnerable population. 6 Conversely, a large study conducted in Kenya found HIV status not to have any associations with CXR findings in PTB-infected individuals. 7 Further analysis of CXRs involving individuals with HIV with PTB in Africa is warranted to close the gap on conflicting findings.
Furthermore, there is limited knowledge regarding the effect of highly active antiretroviral therapy (HAART) on radiological features of HIV-associated PTB. HAART decreases HIV viral load, permits CD4/T-cell immune reconstitution, reduces the risk of TB infection/reactivation, and decreases mortality. 4, 6 However, individuals with HIV on HAART still have a greater risk of TB compared to HIV-uninfected individuals. 8 Previous studies have shown that higher CD4 counts correlate with typical CXR findings of PTB but only a few mention the influence of HAART in the same setting. 9, 10 One small study conducted in West Africa showed that individuals with HIV on HAART showed typical findings of PTB on CXR. 10 However, further research is required to substantiate this finding.
We compared CXRs of adult individuals with HIV and uninfected individuals newly diagnosed with PTB in Soweto, South Africa. Additionally, we compared CXRs of HIV-infected HAART recipients with those who were HAART-naïve. To our knowledge, this is the largest study in a resource poor setting (Soweto in South Africa) comparing radiological features of individuals with laboratory-confirmed PTB by HIV status.
Materials and Methods

Study design
We conducted a cross-sectional analysis of data from two cohorts who were enrolled in clinical studies investigating novel ways of detecting acid fast bacilli in adults with laboratoryconfirmed PTB in Soweto, South Africa. Individuals provided voluntary written informed consent and agreed to have their data used for further research.
For our analysis, we included individuals from both cohorts who were 18 years and older with confirmed PTB (either via Auramine smear, MGIT culture or Gene Xpert on sputum sample) and had both HIV testing and CXRs performed.
Study setting
Both studies were conducted in Soweto, a township of 1.3 million people.
11 Individuals were recruited during 2012-2015 from the township through community outreach efforts as well as community clinics located in and around Chris Hani Baragwanath Academic hospital (CHBAH) which is the largest referral hospital in South Africa; CHBAH experiences an endemic rate of 500 cases per 100 000 population. 12 
Study procedures
Data collected from the cohorts included demographic measures such as gender and age as well as clinical measures such as weight and height. Diagnosis of PTB on sputum was done using Auramine smear, liquid MGIT culture over 42 days and Gene Xpert tests. Furthermore, the cohorts performed HIV and CD4 count testing. Information on HAART usage was elicited from individuals with HIV. Additionally, CXRs were performed by the same independent radiologist firm prior to administration of TB medication. The radiologists were aware of the diagnosis of PTB but were unaware of the HIV and HAART status of individuals. Although different radiologists of the same firm were used, CXRs were analysed in a standardized manner categorizing the presence or absence of cavitations, infiltrates, adenopathy or pleural disease involving either the right or left side of the lung. Cavitations were further categorized as being absent or present, with the size being <4 cm or ≥4 cm. Disease extent is classified by the area of lung involved: less than one quarter, between one quarter and less than one half and one half or more of the entire thoracic cavity or lesion(s) as seen on PA or AP view.
Statistical methods
Baseline characteristics were summarized descriptively using medians and IQRs for continuous variables, while frequencies and proportions were determined for categorical variables. Demographic and clinical characteristics were compared by HIV status. Continuous measures were compared non-parametrically using the Kruskal-Wallis test. The association between HIV status and radiological features of lung disease (infiltrate, adenopathy and pleural disease in the left and right lungs, together with total cavitation and disease extent) was tested by χ 2 analysis. The number of individuals with infiltrates, cavities, adenopathy and pleural disease were presented graphically stratified by HIV status. The association between lung disease and HAART status within the individuals with HIV was also tested by χ 2 analysis. The aim of our sub-analysis was to identify potential differences in CXR patterns among HAART recipients and HAART-naïve individuals. All statistical analyses were performed using SAS Enterprise Guide version 6.1 (SAS Institute, Cary, NC, USA).
Results
We included 474 participants (270 males and 204 females) in our analysis (Figure 1 
Discussion
This is the largest study to document radiological manifestations of PTB in individuals with HIV in Soweto, South Africa. Our study, conducted in a resource-limited setting, demonstrates the varying radiological presentation of PTB in individuals with HIV. Compared to HIV-uninfected individuals, those who had HIV had a higher proportion of infiltrates and a lower proportion of cavitations on CXRs. When cavities were present on CXR, they were smaller and more likely to be confined to less than one quarter of the thoracic chest cavity radiologically than in HIVuninfected individuals. Our study shows a significant association between infiltrates and HIV status. Individuals with HIV present more with infiltrates compared to HIV-uninfected individuals. It may be that individuals with HIV present with a higher proportion of primary TB compared with post-primary TB. 13, 14, 15 However, this is in contrast to another study conducted in India which showed a higher proportion of infiltrates in HIV-uninfected individuals. 5 Our findings are similar to other smaller studies performed in HIV-seropositive individuals co-infected with PTB. 4, 5 These studies suggest that individuals with HIV do not present with cavitations when compared to HIV-uninfected individuals. 16, 17 This is likely due to individuals with HIV not mounting the robust cell-mediated response required to form granulomas and subsequent cavities. 5, 13 Our subset analysis of individuals with HIV showed an association between cavitation size and HAART. Our study shows the unpredictable presentation of PTB in HAART-recipients and HAART-naïve individuals. It is one of the first studies to show HAART recipients presenting with larger cavitations (≥4 cm) compared to HAART naïve individuals. This is likely due to HAART-mediated restitution of immunity, resulting in larger cavitations being formed. Individuals with HIV with CD4 counts>200 were associated with having a higher proportion of infiltrates and cavities that those with CD4≤200. This is in keeping with a better immune system resulting in cavitations in PTB.
The limitations of the study were that this was a secondary data analysis in which additional important variables such as use of immunosupressants, duration of HAART and co-morbid diseases could not be investigated.
Further analysis of the CXRs such as presence or absence of nodules, fibrosis and miliary TB would have also been unique factors to assess but were unavailable due to the standardized method of reporting. 
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Conclusions
PTB typically presents as an upper lobe cavitatory disease on CXR. In a resource-limited setting where the burden of HIVassociated PTB remains high, CXR may become moot as individuals with HIV with PTB are unlikely to present with typical CXR findings. However, the absence of typical findings does not exclude the diagnosis of PTB in the individuals with HIV. A high index of suspicion is required when diagnosing PTB as the clinical and radiological features may differ.
